Purchase Order 75N93019P00575
Award Date 5/22/19
Potential Completion Date 8/11/20
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Quanterix Corporation. The contract, valued at $135,937.50, is for the provision of the Quanterix ELISA (Enzyme-Linked Immunosorbent Assay) System, which is used for ultra-sensitive digital biomarker detection. This contract was set aside for small businesses. Quanterix Corporation is a life sciences company specializing in advanced...
- This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
- The U.S. National Institute on Aging (NIA) awarded a firm-fixed-price purchase order contract to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $172,938.00 contract is for maintenance service on a Simoa HD-X Analyzer used in the agency's biomedical research. The contract has a period of performance through January 11, 2029 and does not have a set-aside designation. Quanterix provides advanced instruments, assay kits, and...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a for-profit manufacturer, for the purchase of Simoa 4-plex 96-well plate assays. The assays will be used to investigate biomarkers related to Alzheimer's disease as part of the Baltimore Longitudinal Study of Aging. The potential value of the award is $197,969.40, and the completion date is December 20, 2021. This...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $209,479.20 firm fixed-price purchase order to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract is for the delivery of assay kits. Quanterix has previously received over $30 million in federal contracts from agencies including the National Institutes of Health, Department of Veterans Affairs, and...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a firm-fixed-price purchase order contract to Quanterix Corporation, a for-profit manufacturer, to provide reagents needed to measure biological molecules in body fluids from a cohort of HIV-1 infected patients and control samples. The contract has a completion date of May 12, 2025 and a potential value of $22,519.40. This award does not include a set-aside...
- Quanterix Corporation has been awarded a firm fixed price purchase order by the National Institutes of Health National Institute on Aging totaling $12,800.88. The contract has no set-aside designation. Under this award, Quanterix will provide its single molecule array platform and associated assay kits and reagents to support the agency's biomarker detection research efforts. Additionally, Quanterix holds an indefinite delivery contract from the Department of Veterans Affairs Veterans Health...
- The contract award to Quanterix Corporation, a life sciences company specializing in digital biomarker detection technology, was issued by the National Institute on Drug Abuse, part of the National Institutes of Health. The $151,775.25 firm-fixed-price purchase order is for the provision of advanced instruments, assay kits, and research services to support biomedical research and diagnostic development. This contract is not designated as a set-aside. Quanterix has also been awarded an indefinite...
- <p>The National Institutes of Health awarded a purchase order to Quanterix Corporation for an N4PA Simoa 2.0 Assay Kit with a ceiling value of $112,969.08 on September 29, 2020. The order carries no small business set-aside. Work is performed at Quanterix's facility in Billerica, Massachusetts, with an ultimate completion date of October 30, 2020. The contract is priced on a firm fixed-price basis.</p>